Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse

Blood

Volumn 109, Issue 7, 2007, Pages 3115-3123

  Chen, Benny J ^a   Deoliveira, Divino ^a   Cui, Xiuyu ^a   Le, Ngocdiep T ^a   Son, Jessica ^a   Whitesides, John F ^a   Chao, Nelson J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; IMMUNE RESPONSE; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION;

EID: 33947573126     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-04-016410     Document Type: Article

References (35)

1. Thomas ED, Blume KG, Forman SJ. Hematopoietic Cell Transplantation. Malden, MA: Blackwell Science; 1999.
2. Ho VT, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood. 2001;98:3192-3204.
3. Korngold B, Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice: prevention by removing mature T cells from marrow. J Exp Med. 1978;148:1687-1698.
4. Ada GL, Nossal G. The clonal-selection theory. Sci Am. 1987;257:62-69.
5. Sprent J. T-memory and B-memory cells. Cell. 1994;76:315-322.
6. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol. 1998;16:201-223.
7. + memory T-cells from the spleen lack Mel-14, the lymph-node homing receptor. J Immunol. 1992;148:324-331.
8. Chen BJ, Cui XY, Sempowski GD, Liu CX, Chao NJ. Transfer of allogeneic CD62L(-) memory T cells without graft-versus-host disease. Blood. 2004;103:1534-1541.
9. Spickett GP, Brandon MR, Mason DW, Williams AF, Woollett GR. MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen. J Exp Med. 1983;158:795-810.
10. + T cells do not induce graft-versus-host disease. J Clin Invest. 2003;112:101-108.
11. + T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity. Blood. 2004;103:3970-3978.
12. low subset. Eur J Immunol. 2004;34:408-417.
13. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708-712.
14. Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol. 2003;4:225-234.
15. Chen BJ, Cui XY, Sempowski GD, Domen J, Chao NJ. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004;103:4344-4352.
16. Hengel RL, Thaker V, Pavlick MV, et al. L-selectin (CD62L) expression distinguishes small resting memory CD4(+) T cells that preferentially respond to recall antigen. J Immunol. 2003;170:28-32.
17. Chen BJ, Cui X, Chao NJ. Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell-depleted bone marrow transplantation. Blood. 2002;99:2235-2240.
18. Anderson BE, McNiff JM, Jain D, et al. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood. 2005;105:2227-2234.
19. Hill GR, Crawford JM, Cooke KR, et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood. 1997;90:3204-3213.
20. Snover DC, Weisdorf SA, Ramsay NK, McGlave P, Kersey JH. Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosis. Hepatology. 1984;4:123-130.
21. Snover DC, Weisdorf SA, Vercellotti GM, et al. A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol. 1985;16:387-392.
22. Heymer B. Clinical and Diagnostic Pathology of Graft-Versus-Host Disease. Heidelberg, Germany: Springer; 2006.
23. Chen BJ, Chen Y, Cui X, Fidler JM, Chao NJ. Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model. Transplantation. 2002;73:115-121.
24. Beilhack A, Schulz S, Baker J, et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood. 2005;106:1113-1122.
25. Kuby J. Immunology. New York, NY: WH Freeman; 1994.
26. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature. 1983;304:30-34.
27. + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood. 2004;104:3804-3812.
28. + regulatory T cells protects from lethal acute GVHD. Blood. 2005;105:2220-2226.
29. Ashwell JD, Chen C, Schwartz RH. High-frequency and nonrandom distribution of alloreactivity in T-cell clones selected for recognition of foreign antigen in association with self class II molecules. J Immunol. 1986;136:389-395.
30. Matesic D, Lehmann PV, Heeger PS. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation. 1998;65:906-914.
31. Gamadia LE, Remmerswaal EB, Surachno S, et al. Cross-reactivity of cytomegalovirus-specific CD8(+) T cells to allo-major histocompatibility complex class I molecules. Transplantation. 2004;77:1879-1885.
32. + T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation. Transplantation. 1995;60:355-361.
33. Zeng D, Hoffmann P, Lan F, et al. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood. 2002;99:1449-1457.
34. Baker MB, Altman NH, Podack ER, Levy RB. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med. 1996;183:2645-2656.
35. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389-399.